Cryoport has formed a strategic partnership with fertility technology company TMRW Life Sciences to provide fertility clinics with temperature-controlled management and transport solutions in the US.
Temperature-controlled supply chain solutions firm Cryoport has partnered with VGXI, a subsidiary of GeneOne Life Science, to support the development of cell and gene therapies and mRNA-based treatments.
For six years now there have been magnetic resonance imaging (MRI) scanners on the market that don’t consume helium but use just small amounts in a closed-loop system. With MRI scanners accounting for a third...
Cryoport has opened a new facility at its integrated supply chain campus in Houston, Texas, to develop its IntegriCell™ cryopreservation services solution.
A recent report highlights the urgent need for a comprehensive study on helium, a critical resource in high magnetic field research, as the global supply continues to face severe constraints.
UNICEF together with the Government of Rivers State, IHS Nigeria, and the Government of Canada have announced the handover of a modern medical oxygen plant – and oxygen delivery devices – to the General Hospital...
In the first half of 2024 (H1), Air Liquide achieved a 2.6% increase in group sales on a comparable basis. However, on a published basis, the industrial gas giant reported a 4.3% decline due to...
Temperature-controlled supply chain solutions firm Cryoport has partnered with cell and gene therapy specialist Minaris Regenerative Medicine to provide fully integrated logistics and manufacturing services for biotechnology and pharmaceutical companies.
Leaders have not done nearly enough to prepare for pandemic threats leaving around eight billion people vulnerable, according to a new report.
Merck is making a €62m commitment to its life science business by aiming to open a 10,000sqm quality control building at its Darmstadt headquarters by mid-2025.
